High levels of cholesterol are a risk factor for atherosclerosis and cardiovascular diseases, which can lead to ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Denali Therapeutics said on Monday its experimental drug failed to meet the main goal of a mid-to-late stage trial involving patients with amyotrophic lateral sclerosis (ALS), a fatal ...

Agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform. CAMBRIDGE, England, Jan. 9, 2025 /PRNewswire/ ...

The primary analysis included 186 subjects who received the therapy and 139 subjects who were given a placebo.

The primary endpoint was the change in the ALS Functional Rating Scale-Revised ... Despite the primary endpoint not being met, the trial's survival data has prompted Corcept to continue with ...

The primary endpoint was the change in the ALS Functional Rating Scale-Revised (ALSFRS-R), which ... Despite the primary endpoint not being met, the trial's survival data has prompted Corcept to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

‘#Cancersurvival rates in South Korea have increased from 54.2% during 2001-2005 to 72.9% during 2018-2022. What factors contributed to this improvement? #Cancer #SouthKorea’ The survival rate ...

Of the 144,447 patients included, the overall melanoma-specific survival rate at 20 years was 91.9%, but survival rates diverged significantly between thickness groups. 94.2% of those with tumors ...

First-of-its-kind research looking at survival rates for patients with incurable larynx cancer has been published. The research, led by cancer doctors and scientists at Newcastle University and ...